Aytu Biopharma, Inc.
AYTU
$2.13
-$0.05-2.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 47.20% | 62.27% | 54.71% | -8.03% | 4.45% |
| Total Receivables | 21.73% | 43.46% | 32.43% | 19.72% | -13.60% |
| Inventory | -21.91% | -13.96% | -5.82% | -16.18% | -14.74% |
| Prepaid Expenses | 7.62% | -10.08% | 10.61% | 2.86% | -23.91% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 20.92% | 33.54% | 27.93% | 1.94% | -11.65% |
|
|
|||||
| Total Current Assets | 20.92% | 33.54% | 27.93% | 1.94% | -11.65% |
| Net Property, Plant & Equipment | -14.82% | -21.23% | 4.66% | -40.01% | -48.04% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -12.77% | -19.09% | -19.55% | -9.93% | -10.33% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -51.51% | -52.36% | -45.98% | 48.59% | 67.81% |
| Total Assets | 4.97% | 7.91% | 5.15% | -3.62% | -11.45% |
|
|
|||||
| Total Accounts Payable | 21.88% | -8.67% | 2.78% | 14.95% | 11.71% |
| Total Accrued Expenses | -15.92% | -17.00% | -31.43% | -22.52% | -15.70% |
| Short-term Debt | 126.20% | 248.31% | 278.41% | 534.28% | 291.03% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.78% | -12.05% | -22.38% | -87.96% | 44.82% |
| Total Finance Division Other Current Liabilities | -11.22% | -5.02% | 5.88% | -10.90% | -4.68% |
| Total Other Current Liabilities | -11.22% | -5.02% | 5.88% | -10.90% | -4.68% |
| Total Current Liabilities | 2.37% | 7.74% | 1.34% | -15.51% | -0.22% |
|
|
|||||
| Total Current Liabilities | 2.37% | 7.74% | 1.34% | -15.51% | -0.22% |
| Long-Term Debt | 0.15% | 0.16% | 0.17% | -- | -33.35% |
| Short-term Debt | 126.20% | 248.31% | 278.41% | 534.28% | 291.03% |
| Capital Leases | -12.03% | -10.58% | 70.71% | 27.84% | 30.89% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 202.81% | 84.79% | 81.27% | -40.79% | -43.84% |
| Total Liabilities | 26.14% | 18.38% | 16.41% | -8.95% | -13.14% |
|
|
|||||
| Common Stock & APIC | 2.26% | 1.84% | 1.38% | 0.72% | 0.91% |
| Retained Earnings | -7.69% | -4.10% | -4.24% | 0.52% | -1.68% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -53.84% | -22.31% | -31.57% | 13.39% | -6.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -53.84% | -22.31% | -31.57% | 13.39% | -6.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -53.84% | -22.31% | -31.57% | 13.39% | -6.36% |
|
|
|||||